Search Orphan Drug Designations and Approvals
-
Generic Name: | Non-replicating recombinant adeno-associated virus serotype 1 vector delivering human GRN gene encoding the protein progranulin |
---|---|
Date Designated: | 01/07/2021 |
Orphan Designation: | Treatment of frontotemporal dementia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Passage Bio, Inc. Commerce Square Two 2001 Market Street Philadelphia, Pennsylvania 19103 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-